Cold medicine ads to be banned

ADVERTISING to consumers of cough and cold products containing pseudoephedrine is likely to be banned from June, following advice to the Federal Health Department.

The interim decision to axe the ads follows the National Drugs and Poisons Schedule Committee (NDPSC) decision in 2005 to reschedule the majority of pseudoephedrine products from Schedule 2 to Schedule 3.

Experts advising on medical scheduling said there was no need for continued advertising of pseudoephedrine, and Schedule 3 products were not usually permitted to be advertised.